Our business model

Bactiguard operates through license partnerships with leading global MedTech companies that apply the infection prevention technology to their medical devices and sell them under their own brand or co-branded with Bactiguard. Our license-focused business model is scalable with operational leverage.

Partnerships across three phases

Bactiguard’s license revenues have three components: we receive revenues for coating and process development, we receive revenues for the right to use the coating technology on medical devices within a specific application and geographical area, and we receive royalties; a variable remuneration once the license partners’ products reach the market. The revenues are generated across three partnership phases: application development, exclusivity, and license.

An application development partner works in close collaboration with Bactiguard’s R&D team, exploring the application of our infection prevention technology to the partners’ underlying device to enhance its performance. The nature of development work means that not every project will succeed, but the learnings are valuable for other application areas.

An exclusivity partner gets exclusive right to apply our coating technology to a certain medical device but has no products in the market yet, for instance due to pending regulatory approvals, which can take time depending on the type of application and its classification.

A license partner has the right to market and sell medical devices with Bactiguard’s coating technology, in a certain region or globally. As the early-stage and application development projects with potential partners make progress, they convert into exclusivity and license partnerships. The early-stage testing and application development projects are executed in a confidential manner to safeguard competitive advantages for both Bactiguard and our partners.

Revenues per partnership phase
Bactiguard reports revenues according to the different partnership phases to ensure transparency of the financial impact of the various partnerships. Notably, not all partnerships will follow all three phases. An agreement with a partner can generate revenues from separate phases and components simultaneously.